Login / Signup

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.

Keith BoweringChristopher CaseJohn HarveyMichael ReevesMichael SampsonRobert StrzinekDitte-Marie BretlerRikke Beck BangBruce W Bode
Published in: Diabetes care (2017)
Faster aspart and IAsp were confirmed noninferior in a basal-bolus regimen regarding change from baseline in HbA1c. Faster aspart improved 1-h PPG with no differences in 2-4-h PPG versus IAsp. Overall hypoglycemia rates were similar except for an increase in 0-2-h postmeal hypoglycemia with faster aspart.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • clinical trial
  • phase ii
  • adipose tissue
  • placebo controlled